<SEC-DOCUMENT>0001209191-22-016533-index.html : 20220304
<SEC-HEADER>0001209191-22-016533.hdr.sgml : 20220304
<ACCEPTANCE-DATETIME>20220304210105
ACCESSION NUMBER:		0001209191-22-016533
CONFORMED SUBMISSION TYPE:	4/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20220301
FILED AS OF DATE:		20220304
DATE AS OF CHANGE:		20220304

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Lebwohl David
		CENTRAL INDEX KEY:			0001810882

	FILING VALUES:
		FORM TYPE:		4/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37766
		FILM NUMBER:		22716026

	MAIL ADDRESS:	
		STREET 1:		C/O INTELLIA THERAPEUTICS, INC.
		STREET 2:		40 ERIE STREET, SUITE 130
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Intellia Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001652130
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				364785571
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		40 ERIE STREET
		STREET 2:		SUITE 130
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		857-285-6200

	MAIL ADDRESS:	
		STREET 1:		40 ERIE STREET
		STREET 2:		SUITE 130
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>4/A
<SEQUENCE>1
<FILENAME>doc4a.xml
<DESCRIPTION>FORM 4/A SUBMISSION
<TEXT>
Document 1 - file: doc4a.html

Document 1 - RAW XML: doc4a.xml

</DOCUMENT>
</SEC-DOCUMENT>